newsfilter
← Latest News
GlobeNewswire·

BeautyHealth Reports Third Quarter 2025 Financial Results

SKIN
  • The Beauty Health Company reported third-quarter 2025 net sales of $70.7 million, a 10.3% decrease from the prior year period.
  • Adjusted EBITDA for Q3 2025 reached $8.9 million, exceeding the top end of the company's guidance range.
  • Gross margin improved to 64.6% in Q3 2025 from 51.6% in Q3 2024, driven by lower inventory charges & a favorable mix shift toward consumables.
  • Delivery systems net sales fell to $20.8 million in Q3 2025, while consumables net sales remained resilient at $49.8 million.
  • The company placed 875 delivery systems during the quarter, down from 1,118 in the same period last year due to a challenging macroeconomic environment.
  • Net loss for Q3 2025 was $11.0 million, an improvement from the $18.3 million loss recorded in Q3 2024.
  • Cash, cash equivalents, & restricted cash totaled approximately $219 million as of September 30, 2025, down from $370 million at the end of 2024.
  • The company updated its full-year 2025 financial guidance to project net sales between $293 million & $300 million.
  • Updated 2025 adjusted EBITDA guidance was raised to a range of $37 million to $39 million.
  • Regional metrics showed declines in delivery system sales across the Americas, APAC, & EMEA regions year-over-year.
  • The company transitioned its China market sales to a distributor partner in Q2 2025, discontinuing direct sales in that region.
  • A conference call to discuss these results is scheduled for November 6, 2025, at 4:30 p.m. ET.